Tabassum et al. [48] stated that adipokine ITLN1 increases insulin-stimulated glucose uptake in adipocytes, and mutation in this gene is responsible for development of insulin resistance in NIDDM. The gene discussed is ITLN1; the disease is Insulin resistance.